FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080325 [Registered on: 11/02/2025] Trial Registered Prospectively
Last Modified On: 07/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Effectiveness of homoeopathic medicine on patients of primary hypothyroidism with dyslipidemia  
Scientific Title of Study   Effectiveness of individualized homoeopathic medicine on primary hypothyroidism with dyslipidemia while assessing the correlation between changes in serum TSH and total cholesterol levels: An open label, prospective, clinical study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jyoti Bhushan Dash 
Designation  Post Graduate Trainee 
Affiliation  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy Department of practice of medicine Opd no-24 Block – GE, Sector - III, Salt Lake, Kolkata – 700106

Kolkata
WEST BENGAL
700106
India 
Phone  7504245877  
Fax    
Email  drjbdash98@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jyoti Bhushan Dash 
Designation  Post Graduate Trainee 
Affiliation  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy Department of practice of medicine Opd no-24 Block – GE, Sector - III, Salt Lake, Kolkata – 700106

Kolkata
WEST BENGAL
700106
India 
Phone  7504245877  
Fax    
Email  drjbdash98@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Gautam Pal 
Designation  Professor, HOD, Department of Practice of Medicine  
Affiliation  National Institute of Homoeopathy 
Address  National Institute of Homoeopathy Department of practice of medicine Opd no-24 Block – GE, Sector - III, Salt Lake, Kolkata – 700106

Kolkata
WEST BENGAL
700106
India 
Phone  9433902556  
Fax    
Email  drgautampal@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Homoeopathy Department of practice of medicine Opd no-24 Block – GE, Sector - III, Salt Lake, Kolkata – 700106 
 
Primary Sponsor  
Name  Dr. Jyoti Bhushan Dash 
Address  National Institute of Homoeopathy Department of practice of medicine Opd no-24 Block – GE, Sector - III, Salt Lake, Kolkata – 700106 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jyoti Bhushan Dash  National institute of homoeopathy  National Institute of Homoeopathy Department of practice of medicine Opd no-24 Block – GE, Sector - III, Salt Lake, Kolkata – 700106
Kolkata
WEST BENGAL 
7504245877

drjbdash98@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
National institute of homoeopathy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E039||Hypothyroidism, unspecified, (2) ICD-10 Condition: E780||Pure hypercholesterolemia,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualised homoeopathic medicine  individualised homoeopathic medicine will be given orally for 6 months and dose, repetition will be selected on the basis of improvement of patient 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  12.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients who are diagnosed with primary hypothyroidism having serum TSH level more than 5mIU per L
and total serum total cholesterol level more than 200mg per dl.
Patients aged between 12 to 65 years of all gender religions and socio economic status.
Patient who are willing to participate in the study and giving informed consent.
If patients taking any Homoeopathic or and Allopathic medicines for primary
hypothyroidism and also willing to participate in the study, they will be enrolled in the study
after washing period 2 months.
Patients who are willing to participate but illiterate then they will be enrolled after verbal
explanation and consent, verified by the physicians signature and patients thumb impression.
Patients who agree to undergo suggested and relevant investigations, if required. 
 
ExclusionCriteria 
Details  Patients having secondary hypothyroidism, congenital hypothyroidism and subclinical
hypothyroidism.
Patients having primary dyslipidemia and secondary dyslipidemia associated of other causes.
Pregnant and lactating women.
Patients with habit of substance abuse and or dependence.
Patients having any psychiatric or life threatening illness or immune compromised state.
Patients taking any other substitutional treatment for primary hypothyroidism.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
serum TSH & total cholesterol levels.  Baseline and 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  18/02/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Null Hypothesis of the study is  there is no significant role of individualized homoeopathic medicine in modifying the hypothyroid state with dyslipidaemia while assessing the correlation between changes in serum TSH and total cholesterol levels.
Alternative Hypothesis of the study is there is significant role of individualized homoeopathic medicine in modifying the hypothyroid state with dyslipidaemia while assessing the correlation between changes in serum TSH and total cholesterol levels.
With the aim to evaluate the effectiveness of individualized homoeopathic medicine on primary hypothyroidism with dyslipidemia while assessing the correlation between changes in serum TSH and total cholesterol levels.
With the objective to assess the effectiveness of individualized homoeopathic medicine on primary hypothyroidism with dyslipidaemia and to identify any correlation between changes in serum TSH levels and changes in serum total cholesterol levels in the age group of 12 to 65 years irrespective of gender.
A detailed case taking will be done using standard proforma of hypothyroid patients associated with dyslipidemia and serum TSH & total cholesterol levels are measured. The outcomes will be assessed initially at base line and after 6 months of treatment
 
Close